Replacing and safeguarding pancreatic β cells for diabetes

Science Translational Medicine

Volumn 7, Issue 316, 2015, Pages

  Bruin, Jennifer E ^a   Rezania, Alireza ^b   Kiefer, Timothy J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; GLUCOSE BLOOD LEVEL;

CARDIOVASCULAR DISEASE; CELL ENCAPSULATION; CELL MATURATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; INSULIN TREATMENT; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; ANIMAL; CELL TRANSPLANTATION; CYTOLOGY; GLUCOSE BLOOD LEVEL; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; BLOOD GLUCOSE; CELL TRANSPLANTATION; DIABETES MELLITUS; HUMANS; IMMUNE SYSTEM; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; PLURIPOTENT STEM CELLS;

EID: 84954270762     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaa9359     Document Type: Review

References (43)

1. A. M. Shapiro, J. R. Lakey, E. A. Ryan, G. S. Korbutt, E. Toth, G. L. Warnock, N. M. Kneteman, R. V. Rajotte, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238 (2000).
2. E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R. Lakey, A. M. Shapiro, Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060-2069 (2005).
3. A. Bruni, B. Gala-Lopez, A. R. Pepper, N. S. Abualhassan, A. J. Shapiro, Islet cell transplantation for the treatment of type 1 diabetes: Recent advances and future challenges. Metabolic Syndrome and Obesity: Targets and Therapy 7, 211-223 (2014).
4. F. B. Barton, M. R. Rickels, R. Alejandro, B. J. Hering, S. Wease, B. Naziruddin, J. Oberholzer, J. S. Odorico, M. R. Garf nkel, M. Levy, F. Pattou, T. Berney, A. Secchi, S. Messinger, P. A. Senior, P. Maf , A. Posselt, P. G. Stock, D. B. Kaufman, X. Luo, F. Kandeel, E. Cagliero, N. A. Turgeon, P. Witkowski, A. Naji, P. J. O'Connell, C. Greenbaum, Y. C. Kudva, K. L. Brayman, M. J. Aull, C. Larsen, T. W. Kay, L. A. Fernandez, M. C. Vantyghem, M. Bellin, A. M. Shapiro, Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 35, 1436-1445 (2012).
5. T. C. Schulz, H. Y. Young, A. D. Agulnick, M. J. Babin, E. E. Baetge, A. G. Bang, A. Bhoumik, I. Cepa, R. M. Cesario, C. Haakmeester, K. Kadoya, J. R. Kelly, J. Kerr, L. A. Martinson, A. B. McLean, M. A. Moorman, J. K. Payne, M. Richardson, K. G. Ross, E. S. Sherrer, X. Song, A. Z. Wilson, E. P. Brandon, C. E. Green, E. J. Kroon, O. G. Kelly, K. A. D'Amour, A. J. Robins, A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLOS ONE 7, e37004 (2012).
6. E. Kroon, L. A. Martinson, K. Kadoya, A. G. Bang, O. G. Kelly, S. Eliazer, H. Young, M. Richardson, N. G. Smart, J. Cunningham, A. D. Agulnick, K. A. D'Amour, M. K. Carpenter, E. E. Baetge, Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulinsecreting cells in vivo. Nat. Biotechnol. 26, 443-452 (2008).
7. K. A. D'Amour, A. G. Bang, S. Eliazer, O. G. Kelly, A. D. Agulnick, N. G. Smart, M. A. Moorman, E. Kroon, M. K. Carpenter, E. E. Baetge, Production of pancreatic hormoneexpressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392-1401 (2006).
8. A. Rezania, J. E. Bruin, M. J. Riedel, M. Mojibian, A. Asadi, J. Xu, R. Gauvin, K. Narayan, F. Karanu, J. J. O'Neil, Z. Ao, G. L. Warnock, T. J. Kiefer, Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61, 2016-2029 (2012).
9. A. Rezania, J. E. Bruin, P. Arora, A. Rubin, I. Batushansky, A. Asadi, S. O'Dwyer, N. Quiskamp, M. Mojibian, T. Albrecht, Y. H. Yang, J. D. Johnson, T. J. Kiefer, Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 32, 1121-1133 (2014).
10. M. C. Nostro, F. Sarangi, S. Ogawa, A. Holtzinger, B. Corneo, X. Li, S. J. Micallef, I. H. Park, C. Basford, M. B. Wheeler, G. Q. Daley, A. G. Elefanty, E. G. Stanley, G. Keller, Stagespecif c signaling through TGFβ family members and WNT regulates patterning and pancreatic specif cation of human pluripotent stem cells. Development 138, 861-871 (2011).
11. F. W. Pagliuca, J. R. Millman, M. Gurtler, M. Segel, A. Van Dervort, J. H. Ryu, Q. P. Peterson, D. Greiner, D. A. Melton, Generation of functional human pancreatic β cells in vitro. Cell 159, 428-439 (2014).
12. H. A. Russ, A. V. Parent, J. J. Ringler, T. G. Hennings, G. G. Nair, M. Shveygert, T. Guo, S. Puri, L. Haataja, V. Cirulli, R. Blelloch, G. L. Szot, P. Arvan, M. Hebrok, Controlled induction of human pancreatic progenitors produces functional β-like cells in vitro. EMBO J. 34, 1759-1772 (2015).
13. W. Jiang, Y. Shi, D. Zhao, S. Chen, J. Yong, J. Zhang, T. Qing, X. Sun, P. Zhang, M. Ding, D. Li, H. Deng, In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 17, 333-344 (2007).
14. C. H. Cho, N. R. Hannan, F. M. Docherty, H. M. Docherty, M. Joao Lima, M. W. Trotter, K. Docherty, L. Vallier, Inhibition of activin/nodal signalling is necessary for pancreatic dif erentiation of human pluripotent stem cells. Diabetologia 55, 3284-3295 (2012).
15. M. C. Nostro, F. Sarangi, C. Yang, A. Holland, A. G. Elefanty, E. G. Stanley, D. L. Greiner, G. Keller, Ef cient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Rep. 4, 591-604 (2015).
16. K. A. D'Amour, A. D. Agulnick, S. Eliazer, O. G. Kelly, E. Kroon, E. E. Baetge, Ef cient dif erentiation of human embryonic stem cells to def nitive endoderm. Nat. Biotechnol. 23, 1534-1541 (2005).
17. A. Rezania, J. E. Bruin, J. Xu, K. Narayan, J. K. Fox, J. J. O'Neil, T. J. Kiefer, Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Stem Cells 31, 2432-2442 (2013).
18. J. E. Bruin, A. Rezania, J. Xu, K. Narayan, J. K. Fox, J. J. O'Neil, T. J. Kiefer, Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. Diabetologia 56, 1987-1998 (2013).
19. O. G. Kelly, M. Y. Chan, L. A. Martinson, K. Kadoya, T. M. Ostertag, K. G. Ross, M. Richardson, M. K. Carpenter, K. A. D'Amour, E. Kroon, M. Moorman, E. E. Baetge, A. G. Bang, Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat. Biotechnol. 29, 750-756 (2011).
20. A. Hayek, G. M. Beattie, Processing, storage and experimental transplantation of human fetal pancreatic cells. Ann. Transplant. 2, 46-54 (1997).
21. B. E. Tuch, A. G. Sheil, A. B. Ng, R. J. Trent, J. R. Turtle, Recovery of human fetal pancreas after one year of implantation in the diabetic patient. Transplantation 46, 865-870 (1988).
22. K. J. Laf erty, L. Hao, Fetal pancreas transplantation for treatment of IDDM patients. Diabetes Care 16, 383-386 (1993).
23. A. Lazarow, L. J. Wells, A. M. Carpenter, O. D. Hegre, R. J. Leonard, R. C. McEvoy, The Banting Memorial Lecture 1973: Islet dif erentiation, organ culture, and transplantation. Diabetes 22, 877-912 (1973).
24. S. Rieck, E. D. Bankaitis, C. V. Wright, Lineage determinants in early endocrine development. Semin. Cell Dev. Biol. 23, 673-684 (2012).
25. A. Rezania, M. J. Riedel, R. D. Wideman, F. Karanu, Z. Ao, G. L. Warnock, T. J. Kiefer, Production of functional glucagon-secreting α-cells from human embryonic stem cells. Diabetes 60, 239-247 (2011).
26. C. L. Basford, K. J. Prentice, A. B. Hardy, F. Sarangi, S. J. Micallef, X. Li, Q. Guo, A. G. Elefanty, E. G. Stanley, G. Keller, E. M. Allister, M. C. Nostro, M. B. Wheeler, The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic β cells. Diabetologia 55, 358-371 (2012).
27. S. H. Lee, E. Hao, A. Y. Savinov, I. Geron, A. Y. Strongin, P. Itkin-Ansari, Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: Implications for diabetes cell therapies. Transplantation 87, 983-991 (2009).
28. K. Kirk, E. Hao, R. Lahmy, P. Itkin-Ansari, Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. Stem Cell Res. 12, 807-814 (2014).
29. E. Motte, E. Szepessy, K. Suenens, G. Stange, M. Bomans, D. Jacobs-Tulleneers-Thevissen, Z. Ling, E. Kroon, D. Pipeleers Beta Cell Therapy Consortium EU-FP7, Composition and function of macroencapsulated human embryonic stem cell-derived implants: Comparison with clinical human islet cell grafts. Am. J. Physiol. Endocrinol. Metab. 307, E838-E846 (2014).
30. G. L. Szot, M. Yadav, J. Lang, E. Kroon, J. Kerr, K. Kadoya, E. P. Brandon, E. E. Baetge, H. Bour-Jordan, J. A. Bluestone, Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm. Cell Stem Cell 16, 148-157 (2015).
31. A. D. Agulnick, D. M. Ambruzs, M. A. Moorman, A. Bhoumik, R. M. Cesario, J. K. Payne, J. R. Kelly, C. Haakmeester, R. Srijemac, A. Z. Wilson, J. Kerr, M. A. Frazier, E. J. Kroon, K. A. D'Amour, Insulin-producing endocrine cells dif erentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Transl. Med. 4, 1214-1222 (2015).
32. A. R. Pepper, C. Gall, D. M. Mazzuca, C. W. Melling, D. J. White, Diabetic rats and mice are resistant to porcine and human insulin: Flawed experimental models for testing islet xenografts. Xenotransplantation 16, 502-510 (2009).
33. J. E. Bruin, A. Asadi, J. K. Fox, S. Erener, A. Rezania, T. J. Kieffer, Accelerated maturation of human stem cell-derived pancreatic progenitor cells into insulin-secreting cells in immunodef cient rats relative to mice. Stem Cell Rep. 10.1016/j.stemcr.2015.10.013 (2015).
34. M. R. Rickels, M. H. Schutta, J. F. Markmann, C. F. Barker, A. Naji, K. L. Tef , β-Cell function following human islet transplantation for type 1 diabetes. Diabetes 54, 100-106 (2005).
35. S. Gargani, J. Thevenet, J. E. Yuan, B. Lefebvre, N. Delalleau, V. Gmyr, T. Hubert, A. Duhamel, F. Pattou, J. Kerr-Conte, Adaptive changes of human islets to an obesogenic environment in the mouse. Diabetologia 56, 350-358 (2013).
36. J. E. Bruin, N. Saber, N. Braun, J. K. Fox, M. Mojibian, A. Asadi, C. Drohan, S. O'Dwyer, D. S. Rosman-Balzer, V. A. Swiss, A. Rezania, T. J. Kiefer, Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs. Stem Cell Rep. 4, 605-620 (2015).
37. P. Rorsman, M. Braun, Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 75, 155-179 (2013).
38. C. Zhang, T. Moriguchi, M. Kajihara, R. Esaki, A. Harada, H. Shimohata, H. Oishi, M. Hamada, N. Morito, K. Hasegawa, T. Kudo, J. D. Engel, M. Yamamoto, S. Takahashi, MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell. Biol. 25, 4969-4976 (2005).
39. T. A. Matsuoka, I. Artner, E. Henderson, A. Means, M. Sander, R. Stein, The MafA transcription factor appears to be responsible for tissue-specif c expression of insulin. Proc. Natl. Acad. Sci. U.S.A. 101, 2930-2933 (2004).
40. T. van der Meulen, R. Xie, O. G. Kelly, W. W. Vale, M. Sander, M. O. Huising, Urocortin 3 marks mature human primary and embryonic stem cell-derived pancreatic α and β cells. PLOS ONE 7, e52181 (2012).
41. T. van der Meulen, C. J. Donaldson, E. Caceres, A. E. Hunter, C. Cowing-Zitron, L. D. Pound, M. W. Adams, A. Zembrzycki, K. L. Grove, M. O. Huising, Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat. Med. 21, 769-776 (2015).
42. I. Cebola, S. A. Rodriguez-Segui, C. H. Cho, J. Bessa, M. Rovira, M. Luengo, M. Chhatriwala, A. Berry, J. Ponsa-Cobas, M. A. Maestro, R. E. Jennings, L. Pasquali, I. Moran, N. Castro, N. A. Hanley, J. L. Gomez-Skarmeta, L. Vallier, J. Ferrer, TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors. Nat. Cell Biol. 17, 615-626 (2015).
43. A. Wang, F. Yue, Y. Li, R. Xie, T. Harper, N. A. Patel, K. Muth, J. Palmer, Y. Qiu, J. Wang, D. K. Lam, J. C. Raum, D. A. Stoffers, B. Ren, M. Sander, Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates. Cell Stem Cell 16, 386-399 (2015).